Advertisement

Membrane Cofactor Protein

  • M. K. Liszewski
  • J. P. Atkinson
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 178)

Abstract

Membrane cofactor protein (MCP, CD46) is a widely distributed regulatory protein that inhibits complement activation on host cells. Except for erythrocytes, it has been found on every cell examined (Liszewski et al. 1991 ). Cole et al. (1985) originally identified MCP as a third class, in addition to CR1 and CR2, of electrophoretically distinct, C3 binding, membrane proteins of human peripheral blood leukocytes. Initially termed gp45–70, to reflect its electrophoretic mobility on SDS-PAGE, the common name was changed to MCP when its cofactor activity was recognized (Seya et al. 1986). MCP was hypothesized and subsequently found to belong to a family of structurally, functionally, and genetically related proteins collectively termed the regulators of complement activation (RCA) (DeCordoba et al. 1984, 1985; Holers et al. 1985; Hourcade et al. 1989). Recently, MCP was given its leukocyte differentiation number (CD46) and a monoclonal antibody (E4.3) was designated as the standard typing reagent (Hadam 1990; Purcell et al. 1989a). This chapter will review our current understanding of the structure and function of MCP, emphasizing recent contributions made possible by molecular analyses (Post et al. 1991).

Keywords

Herpes Simplex Virus Membrane Cofactor Protein Cofactor Activity Decay Accelerate Factor Acrosomal Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams EM, Brown MC, Nunge M, Krych M, Atkinson JP (1991) Contribution of the repeating domains of membrane cofactor protein (MCP; CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147: 3005–3011PubMedGoogle Scholar
  2. Anderson DJ, Michaelson JS, Johnson PM (1989) Trophoblast/leukocyte-common antigen is expressed by human testicular germ cells and appears on the surface of acrosome-reacted sperm. Biol Reprod 41: 285–293PubMedCrossRefGoogle Scholar
  3. Andrews PW, Knowles BB, Parkar M, Pym B, Stanley K, Goodfellow PN (1985) A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1. J Ann Hum Genet 49: 31–39CrossRefGoogle Scholar
  4. Atkinson JP, Farries T (1987) Separation of self from non-self in the complement system. Immunol Today 8: 212–215CrossRefGoogle Scholar
  5. Ballard L, Seya T, Teckman J, Lublin DM, Atkinson JP (1987) A polymorphism of the complement regulatory protein MCP (membrane cofactor protein of gp45–70). J Immunol 138: 3850–3855PubMedGoogle Scholar
  6. Ballard LL, Bora NS, Yu GH, Atkinson JP (1988) Biochemical characterization of membrane cofactor protein of the complement system. J Immunol 141: 3923–3939PubMedGoogle Scholar
  7. Birmingham DJ, Cosio FG (1989) Characterization of the baboon erythrocyte C3b-binding protein. J Immunol 142: 3140–3144PubMedGoogle Scholar
  8. Birmingham DJ, Cosio FG, McCourt DW, Atkinson JP (1991) N-terminus amino acid analysis of the baboon erythrocyte C3b receptor. FASEB 5: JA1716Google Scholar
  9. Bora NS, Lublin DM, Kumar BV, Hockett RD, Holers, VM, Atkinson JP (1989) Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3´ end of the C3b/C4b receptor gene. J Exp Med 169: 597–602PubMedCrossRefGoogle Scholar
  10. Bora NS, Post TW, Atkinson JP (1991) Membrane cofactor protein (MCP) of the complement system: A Hind III RFLP that correlates with the expression polymorphism. J Immunol 146: 2821–2825PubMedGoogle Scholar
  11. Campbell RD, Law SKA, Reid KBM, Sim RB (1988) Structure, organization and regulation of the complement genes. Annu Rev Immunol 6: 161–195PubMedCrossRefGoogle Scholar
  12. Carel JC, Myones BL Frazier B, Holers VM (1990) Structural requirements for C3d, g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem 265: 12293–12299PubMedGoogle Scholar
  13. Cervoni F, Oglesby TJ, Nickells M, Milesi-Fluet C, Fenichel P, Atkinson JP, Hsi B-L (1992) Identification and characterization of membrane cofactor protein (MCP) of human spermatozoa. J Immunol (in press)Google Scholar
  14. Cho S-W, Oglesby TJ, Hsi B-L, Adams EM, Atkinson JP (1991) Characterization of three monoclonal antibodies to membrane cofactor protein (MCP) of the complement system and quantitation of MCP by radioassay. Clin Exp Immunol 83: 257–261PubMedCrossRefGoogle Scholar
  15. Cole J, Housley GA, Dykman TR, MacDermott RP, Atkinson JP (1985) Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci USA 82: 859–863PubMedCrossRefGoogle Scholar
  16. DeCordoba R, Dykman TR, Ginsberg-Fellner F, Ercilla G, Aqua M, Atkinson JP, Rubinstein P (1984) Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4bp) and for the C3b/C4b receptor. Proc Natl Acad Sci USA 81: 7890–7892CrossRefGoogle Scholar
  17. Decordoba SR, Lublin DM, Rubinstein P, Atkinson JP (1985) Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med 161: 1189–1195CrossRefGoogle Scholar
  18. Farries TC, Atkinson JP (1991) Evolution of the complement system. Immunol Today 12: 295–300PubMedCrossRefGoogle Scholar
  19. Farries TC, Steuer Knutzen KL, Atkinson JP (1990) Evolutionary implications of a new bypass activation pathway of the complement system. Immunol Today 11: 78–80PubMedCrossRefGoogle Scholar
  20. Fenichel P, Hsi B-L, Farahifar D, Donzeau M, Barrier-Delpech D, Yeh CJG (1989) Evaluation of the human sperm acrosome reaction using a monoclonal antibody, GB24, and fluorescence- activated cell sorter. J Reprod Fertil 897: 699–706Google Scholar
  21. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB (1984) Glycoprotein C of herpes simplex virus 1 acts as a receptor for C3b complement component on infected cells. Nature 309: 633–637PubMedCrossRefGoogle Scholar
  22. Fries LF, Friedman HM, Cohen GH, Eisenberg RJ, Hammer CH, Frank MM (1986) Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137: 1636–1640PubMedGoogle Scholar
  23. Fujita T, Inoue T, Ogawa K, Iida K, Tamura N (1987) The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J Exp Med 166: 1221–1228PubMedCrossRefGoogle Scholar
  24. Goujet-Zalc C, Ripoche J, Guercy A, Mahouy G, Fontaine M (1987) Marmoset red blood cell receptor for membrane associated complement components is not related to human CR1: Partial characterization of the C3-binding proteins responsible for the spontaneous rosette formation between marmoset red blood cells and human leukocytes. Cell Immunol 109: 282–294PubMedCrossRefGoogle Scholar
  25. Hadam MR (1990) Cluster Report: CD46. In: Knapp W (ed) Leukocyte typing IV. University of Oxford Press, Oxford, p 649Google Scholar
  26. Holers VM, Cole JL, Lublin DM, Seya T, Atkinson JP (1985) Human C3b- and C4b-regulatory proteins: a new multi-gene family. Immunol Today 6: 188–192CrossRefGoogle Scholar
  27. Hourcade D, Holers VM, Atkinson JP (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45: 381–416PubMedCrossRefGoogle Scholar
  28. Hsi B-L, Jing C, Yeh G, Fenichel P, Samson M, Grivaux C (1988) Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen. Am J Reprod Immunol Microbiol 18: 21–27PubMedGoogle Scholar
  29. Hsi B-L, Hunt JS, Atkinson JP (1991) Differential expression of complement regulatory proteins on subpopulations of human trophoblast cells. J Reprod Immunol 19: 209–223PubMedCrossRefGoogle Scholar
  30. Hunt JS, Hsi B-L (1990) Evasive strategies of trophoblast cells: selective expression of membrane antigens. Am J Reprod Immunol Microbiol 23: 57–63Google Scholar
  31. Jentoft N (1990) Why are proteins O’glycosylated? Trends Biochem Sci 15: 291–294PubMedCrossRefGoogle Scholar
  32. Johnson PM, Cheng HM, Molloy CM, Stern CMM, Slade MB (1981) Human trophoblast-specific surface antigens identified using monoclonal antibodies. Am J Reprod Immunol 1: 246–254Google Scholar
  33. Kinoshita T, Takata Y, Kozono H, Takada J, Hong K, Inoue K (1988) C5 convertase of the alternative pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. J Immunol 141: 3895–3901PubMedGoogle Scholar
  34. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT (1988) Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med 168: 1699–1717PubMedCrossRefGoogle Scholar
  35. Kotwal GJ, Moss B (1988) Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature 335: 176–178PubMedCrossRefGoogle Scholar
  36. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B (1990) Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250: 827–830PubMedCrossRefGoogle Scholar
  37. Krych M, Hourcade D, Atkinson JP (1991) Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci USA 88: 4353–4357PubMedCrossRefGoogle Scholar
  38. Lachmann PJ, Nicol PAE (1973) Reaction mechanism of the alternative pathway of complement fixation. Lancet i: 465–467CrossRefGoogle Scholar
  39. Liszewski MK, Post TW, Atkinson JP (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9: 431–455PubMedCrossRefGoogle Scholar
  40. Lowell AC, Klickstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM (1989) Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain in complement receptor type 2. J Exp Med 170: 1931–1946PubMedCrossRefGoogle Scholar
  41. Lublin D, Atkinson JP (1989a) Decay accelerating factor: molecular biology, chemistry, and function. Annu Rev Immunol 7: 35–58PubMedCrossRefGoogle Scholar
  42. Lublin DM, Atkinson JP (1989b) Decay-accelerating factor and membrane cofactor protein. In: Lambris JD (ed) The third component of complement. Chemistry and biology. Springer, Berlin Heidelberg New York, pp 123–145 (Current topics in microbiology and immunology, vol 153)Google Scholar
  43. Lublin D, Atkinson JP (1992) Decay accelerating factor and membrane cofactor protein. In: Sim RB (ed) Biochemistry and molecular biology of complement. MTP Press, Lancaster (in press)Google Scholar
  44. Lublin DM, Liszewski MK, Post TW, Arce MA, LeBeau MM, Rebentisch MB, Lemons RS, Seya T, Atkinson JP (1988) Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP): evidence for inclusion in the multi-gene family of complement-regulatory proteins. J Exp Med 168: 181–194PubMedCrossRefGoogle Scholar
  45. Manthei U, Nickells M, Barnes SH, Ballard LL, Cui W, Atkinson JP (1988) Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes: a CR1 -like candidate for the immune adherence receptor. J Immunol 140: 1228–1235PubMedGoogle Scholar
  46. McNearney TA, Odell C, Holers VM, Spear PG, Atkinson JP (1987) Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med 166: 1525–1535PubMedCrossRefGoogle Scholar
  47. McNearney T, Ballard L, Seya T, Atkinson JP (1989) Membrane cofactor protein of complement is present on human fibroblast, epithelial and endothelial cells. J Clin Invest 84: 538–545PubMedCrossRefGoogle Scholar
  48. Nickells MW, Atkinson JP (1990) Characterization of CR1 and membrane cofactor protein-like proteins of two primates. J Immunol 144: 4262–4268PubMedGoogle Scholar
  49. Platt JL, Oglesby TJ, Vercellotti GM, Dalmasso AP, Matas AJ, Bolman RM, Najarian JS, Bach FH (1990) Transplantation of discordant xenografts: a review of progress. Immunol Today 12: 450–456CrossRefGoogle Scholar
  50. Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP (1991) Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms which correlate with protein phenotype. J Exp Med 174: 93–102PubMedCrossRefGoogle Scholar
  51. Purcell DFJ, Clark GJ, Brown MA, McKenzie IFC, Sandrin MS, Deacon NJ (1989a) HuLy-m5, an antigen sharing epitopes with envelope gp70 molecules of primate retroviruses has a structural relationship with complement regulatory molecules. In: Knapp W (ed) Leukocyte typing IV. University of Oxford Press, Oxford, pp 653–655Google Scholar
  52. Purcell DFJ, McKenzie IFC, Lublin DM, Johnson PM, Atkinson JP, Oglesby TJ, Deacon NJ (1990a) The human cell-surface glycoproteins HuLy-m5, membrane cofactor protein (MCP) of the complement system, and trophoblast-leukocyte common (TLX) antigen are CD46. Immunology 70: 155–161PubMedGoogle Scholar
  53. Purcell DFJ, Deacon NJ, Andrew SM, McKenzie IFC (1990b) Human non-lineage antigen CD46 (HuLy-m5): purification and partial sequencing demonstrates structural homology with complement regulating glycoproteins. Immunogenetics 31: 21–28PubMedCrossRefGoogle Scholar
  54. Reddy P, Caras I, Krieger M (1989) Effects of O-linked glycosylation on the cell surface expression and stability of decay accelerating factor, a glycophospholipid-anchored membrane protein. J Biol Chem 264: 17329–17336PubMedGoogle Scholar
  55. Rey-Campos J, Baeza-Sanz D, de Cordoba SR (1990) Physical linkage of the human genes coding for complement factor H and coagulation Factor XIIIB subunit. Genomics 7: 644–666PubMedCrossRefGoogle Scholar
  56. Risk JM, Flanagan BF, Johnson PM (1991) Polymorphism of the human CD46 gene in normal individuals and in recurrent spontaneous abortion. Hum Immunol 30: 162–167PubMedCrossRefGoogle Scholar
  57. Seya T, Atkinson JP (1989) Functional properties of membrane cofactor protein of complement. Biochem J 264: 581–588PubMedGoogle Scholar
  58. Seya T, Turner J, Atkinson JP (1986) Purification and characterization of membrane cofactor protein (gp45–70) which is a cofactor for cleavage of C3b and C4b. J Exp Med 163: 837–855PubMedCrossRefGoogle Scholar
  59. Seya T, Ballard L, Bora N, McNearney T, Atkinson JP (1988) Distribution of membrane cofactor protein (MCP) of complement on human peripheral blood cells. Eur J Immunol 18: 1289–1294PubMedCrossRefGoogle Scholar
  60. Seya T, Hara T, Matsumoto MG, Akedo A (1990a) Quantitative analysis of membrane cofactor protein (MCP) of complement. J Immunol 145: 238–245PubMedGoogle Scholar
  61. Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H (1990b) Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172: 1673–1677PubMedCrossRefGoogle Scholar
  62. Seya T, Okada M, Matsumoto M, Hong K, Kinoshita T, Atkinson JP (1991) Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP). Mol Immunol 28: 1137–1147PubMedCrossRefGoogle Scholar
  63. Sparrow RL, McKenzie IFC (1983) HuLy-m5: a unique antigen physically associated with HLA molecules. Hum Immunol 7: 1–15PubMedCrossRefGoogle Scholar
  64. Stern PL, Beresford N, Thompson S, Johnson PM, Webb PD, Hole N (1986) Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody. J Immunol 137: 1604–1609PubMedGoogle Scholar
  65. Turner JR (1984) Structural and functional studies of the C3b and C4b binding proteins of a human monocyte-like cell line (U937) Masters thesis. Washington University, St LouisGoogle Scholar
  66. Weisman HF, Bartow T, Leppo MK, Marsh Jr HC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146–151PubMedCrossRefGoogle Scholar
  67. Oglesby TJ, White D, Tedja I, Liszewski K, Wright L, Van den Bogarde J, Atkinson JP (1992) Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein (MCP) and decay accelerating factor (DAF). Trans Assoc Amer Phys (in press)Google Scholar
  68. Wong WW, Fearon DT (1985) p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J Immunol 134: 4048–4056PubMedGoogle Scholar
  69. Yeh CG, Marsh Jr HC, Carson GR, Berman L, Concino MF, Scesney SM, Kuestner RE, Skibbens R, Donahue KA, Ip SH (1991) Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J Immunol 146: 250–256PubMedGoogle Scholar
  70. Yu G, Holers VM, Seya T, Ballard L, Atkinson JP (1986) Identification of a third component of complement-binding glycoprotein of human platelets. J Clin Invest 78: 494–501PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • M. K. Liszewski
    • 1
  • J. P. Atkinson
    • 1
  1. 1.Howard Hughes Medical Institute Laboratories, Department of Medicine, Division of RheumatologyWashington University School of MedicineSt. LouisUSA

Personalised recommendations